PH-like acute lymphoblastic leukemia

Clinical trials for PH-like acute lymphoblastic leukemia explained in plain language.

Never miss a new study

Get alerted when new PH-like acute lymphoblastic leukemia trials appear

Sign up with your email to follow new studies for PH-like acute lymphoblastic leukemia, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet finished but already full! 2

New hope for young leukemia patients: targeted drug added to chemo

Disease control Recruiting now

This early-stage trial is testing whether adding the drug ruxolitinib (Jakafi) to standard chemotherapy is safe for adolescents and young adults (ages 12-39) newly diagnosed with Ph-like acute lymphoblastic leukemia (ALL), an aggressive subtype. The study will enroll 15 participa…

Matched conditions: PH-LIKE ACUTE LYMPHOBLASTIC LEUKEMIA

Phase 1 • Sponsor: University of Chicago • Aim: Disease control

Last updated Jul 01, 2026 00:00 UTC

PH-like acute lymphoblastic leukemia

Get alerted when new PH-like acute lymphoblastic leukemia trials appear

New hope for young leukemia patients: targeted drug added to chemo